Compare ICCC & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICCC | TACT |
|---|---|---|
| Founded | 1982 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.8M | 35.7M |
| IPO Year | 1995 | 1996 |
| Metric | ICCC | TACT |
|---|---|---|
| Price | $10.02 | $3.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 28.0K | ★ 57.9K |
| Earning Date | 05-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 53.85 | ★ 87.88 |
| EPS | ★ 0.21 | 0.07 |
| Revenue | ★ $26,493,169.00 | N/A |
| Revenue This Year | N/A | $10.36 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $55.57 |
| Revenue Growth | ★ 51.64 | N/A |
| 52 Week Low | $4.52 | $3.06 |
| 52 Week High | $10.25 | $5.70 |
| Indicator | ICCC | TACT |
|---|---|---|
| Relative Strength Index (RSI) | 73.69 | 63.56 |
| Support Level | $5.85 | $3.67 |
| Resistance Level | N/A | $4.76 |
| Average True Range (ATR) | 0.50 | 0.20 |
| MACD | 0.12 | 0.05 |
| Stochastic Oscillator | 97.37 | 80.51 |
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.